Trial intelligence / Profile preview

Retapamulin for Reducing MRSA Nasal Carriage

NCT01461668Phase 4Completed

Sponsor
University of California, Irvine
Start
Jul 2012
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of retapamulin in Staphylococcus aureus colonization, sponsored by University of California, Irvine. Started Jul 2012; status: completed.

02

Drugs

retapamulin
03

Conditions

Staphylococcus aureus colonization

Beyond the preview

Go deeper on NCT01461668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01461668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call